Related Experiment Video
Updated: Jul 4, 2026
Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
Published on: November 10, 2023
C3d and C4d deposition early after lung transplantation
Glen P Westall1, Greg I Snell, Catriona McLean
1Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Monash University Medical School, Melbourne, Victoria, Australia. g.westall@alfred.org.au
Background:
Complement staining as a predictor of antibody-mediated rejection (AMR) after lung transplantation continues to be debated.
Methods:
In a cohort of 33 lung transplant recipients (LTRs) we assessed early post-transplant (
Results:
Significant C3d and C4d staining (i.e., Grade >or=2 on more than one occasion) was observed in 20 and 11 LTRs, respectively. Complement staining was increased in LTRs with severe primary graft dysfunction or airway infection, but was not associated with acute cellular or chronic rejection, or with morphologic features of AMR. In a sub-group analysis we identified 9 LTRs who developed early bronchiolitis obliterans syndrome (BOS) in the absence of acute cellular rejection or cytomegalovirus reactivation, but they had significant lung allograft C3d/C4d deposition along with corroborative light-microscopic features suggestive of AMR.
Conclusions:
Complement activation, as judged by lung allograft deposition of C3d/C4d, is common early post-lung transplant and may be triggered by primary graft dysfunction and/or airway infection, and may play a role in the development of early BOS.
